CarlVictorCrawfordMD

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

Assistant Professor, Medicine, Weill Cornell Medical College

Overview of Dr. Crawford

Dr. Carl Crawford is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and Memorial Sloan Kettering Cancer Center. He received his medical degree from Yale School of Medicine and has been in practice 16 years. He is one of 302 doctors at New York-Presbyterian Hospital and one of 35 doctors at Memorial Sloan Kettering Cancer Center who specialize in Gastroenterology. He has more than 40 publications and over 500 citings.

Office
1305 York Ave 4th Floor
New York, NY 10021
Book by Phone+1(321) 504-5894

Education & Training

Yale School of MedicineClass of 2001
Memorial Sloan Kettering Cancer CenterFellowship, Advanced Endoscopy

Certifications & Licensure

NY State Medical License 2004 - 2025

Clinical Trials

SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2

Publications & Presentations

PubMed

54 citations
Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation
Svetlana Lima, Lasha Gogokhia, Monica Viladomiu, Lance Chou, Gregory G. Putzel
Gastroenterology. 2021-10-02
127 citations
Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection.
Matthew Magruder, Adam N. Sholi, Catherine Gong, Lisa Zhang, Emmanuel Edusei
Nature Communications. 2019-12-04
311 citations
Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis
Lasha Gogokhia, Kate Buhrke, Rickesha Bell, Brenden Hoffman, D. Garrett Brown
Cell Host & Microbe. 2019-02-13

Journal Articles

To Scope or Not to Scope? The Safety of Upper Endoscopy in the Setting of Pulmonary Embolism
Russell Rosenblatt, Zaid Tafesh, David Wan, Carl Crawford, Nature
Gut Microbiota Dysbiosis and Diarrhea in Kidney Transplant Recipients
Eric Pamer, Manikkam Suthanthiran, Ying Taur, Michael J Satlin, Darshana Dadhania, John Richard Lee, Carl Crawford, Michelle Lubetzky, American journal of transplantation

Lectures

Update in Gastroenterology, Hepatology & Nutrition , 29th Annual Postgraduate Medicine Course
College of Physicians & Surgeons, Columbia University, New York, New York - 11/30/2012

Press Mentions

Vowst Becomes First FDA-Approved Fecal Microbiota PillApril 27th, 2023
FDA OKs First Poop-Based Oral TherapyApril 27th, 2023
Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWSTTM (Fecal Microbiota Spores, Live-Brpk) for Prevention of Recurrence of C. Difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDIApril 26th, 2023
Join now to see all